Oxidized LDL autoantibodies are related to apolipoprotein E phenotype, independently of postprandial change in plasma triglycerides and LDL size, among patients with angiographically verified coronary artery disease and healthy controls.

[1]  B. Fagerberg,et al.  Antibodies to Oxidized LDL in Relation to Intima-Media Thickness in Carotid and Femoral Arteries in 58-Year-Old Subjectively Clinically Healthy Men , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[2]  D. Steinberg,et al.  The oxidative modification hypothesis of atherogenesis: an overview. , 2000, Free radical biology & medicine.

[3]  R. Klein,et al.  Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes. , 2000, Diabetes.

[4]  T. Lehtimäki,et al.  Association between Apolipoprotein E Alleles and Autoantibodies against Oxidised Low-Density Lipoprotein , 2000, Clinical chemistry and laboratory medicine.

[5]  M. Austin.  Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype , 2000, Current atherosclerosis reports.

[6]  J. Witztum,et al.  Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis , 2000, Journal of internal medicine.

[7]  G. Hansson,et al.  Immunomodulation of atherosclerosis: myth and reality , 2000, Journal of internal medicine.

[8]  F. Raal,et al.  Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia , 2000, Annals of clinical biochemistry.

[9]  T. Shoji,et al.  Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[10]  G. Siest,et al.  Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. , 2000, Free radical biology & medicine.

[11]  M. Emoto,et al.  Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. , 2000, Atherosclerosis.

[12]  G. Breithardt,et al.  Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. , 2000, European heart journal.

[13]  M. Uusitupa,et al.  Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Dart,et al.  Independent effects of Apo E phenotype and plasma triglyceride on lipoprotein particle sizes in the fasting and postprandial states. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[15]  K. Forrest,et al.  Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. , 1999, Diabetes.

[16]  Y. Shoenfeld,et al.  Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty. , 1999, Immunology letters.

[17]  M. Taskinen,et al.  Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. , 1999, Diabetes care.

[18]  R. Bakalova,et al.  Serum level of IgG autoantibodies against oxidized low density lipoproteins and lag-phase of serum oxidation in coronary heart disease--inverse correlation. , 1999, General physiology and biophysics.

[19]  R W Evans,et al.  Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. , 1999, Clinical immunology.

[20]  S. Humphries,et al.  Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study. , 1997, Atherosclerosis.

[21]  T. Lehtimäki,et al.  Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[22]  A Afek,et al.  Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. , 1998, Atherosclerosis.

[23]  L. Neveux,et al.  The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent , 1998, International journal of clinical & laboratory research.

[24]  A. Yonemura,et al.  Beneficial effects of alcohol withdrawal on LDL particle size distribution and oxidative susceptibility in subjects with alcohol-induced hypertriglyceridemia. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[25]  A. Dart,et al.  Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. , 1997, Atherosclerosis.

[26]  B. Howard,et al.  Apolipoprotein E polymorphism and LDL size in a biethnic population. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Jonathan D. Smith,et al.  Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.

[28]  J. Boer,et al.  Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. , 1996, Atherosclerosis.

[29]  G. Siest,et al.  Apolipoprotein E: an important gene and protein to follow in laboratory medicine. , 1995, Clinical chemistry.

[30]  H. Jansen,et al.  Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B. , 1995, Atherosclerosis.

[31]  L. Tenkanen,et al.  Antibody against oxidized low-density lipoprotein predicting myocardial infarction. , 1994, Archives of internal medicine.

[32]  T. Hayek,et al.  Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. , 1994, Biochemical and biophysical research communications.

[33]  T. Lehtimäki,et al.  Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. , 1994, Atherosclerosis.

[34]  P. de Knijff,et al.  Relationship between apolipoprotein E and low density lipoprotein particle size. , 1993, Atherosclerosis.

[35]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[36]  T. Lehtimäki,et al.  Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. , 1990, Journal of lipid research.

[37]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[38]  Mircea Eliade,et al.  Myth and Reality , 2014 .